ArticleAmerican journal of translational research2022

Piceatannol alleviates glucolipotoxicity induced vascular barrier injury through inhibition of the ROS/NF-kappa B signaling pathway.

Zhen Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.